SCHEMBL351486

SCHEMBL351486

O=C(O)c1nc2ccccc2nc1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 1.00
MAPT P10636 2/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
PIM1 P11309 3/20 0.55
ALOX15 P16050 2/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
KDM4E B2RXH2 2/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
DYRK1A Q13627 4/20 0.50
MGAM O43451 2/20 0.50
DYRK1B Q9Y463 3/20 0.45
CLK1 P49759 2/20 0.45
CDK9 P50750 2/20 0.45
DYRK2 Q92630 2/20 0.45
CLK4 Q9HAZ1 2/20 0.45
CDK5 Q00535 1/20 0.45
CLK2 P49760 1/20 0.45
GSK3B P49841 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29860539 1.00 ALDH1A1 (1.00) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL28384025 0.97 ALDH1A1 (0.95) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL28296154 0.89 ALDH1A1 (0.79) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL9357074 0.87 ALDH1A1 (0.76) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL42617 0.86 ALDH1A1 (0.75) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL27541390 0.84 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL2056931 0.84 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL29670121 0.84 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL1759326 0.84 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15
SCHEMBL634399 0.84 ALDH1A1 (0.72) ALDH1A1MAPTSMN1; SMN2PIM1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042084-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP GENERAL ELECTRIC TECHNOLOGY GMBH (CH) 2026-02-12 US claimed
WO-2025238576-A1 SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION Nuovo Pignone Tecnologie – S.r.l. (IT) 2025-11-20 WO claimed
US-20250354659-A1 SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION NUOVO PIGNONE TECNOLOGIE – S R L (IT) 2025-11-20 US claimed
EP-4556112-A2 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS General Electric Technology GmbH (CH) 2025-05-21 EP claimed
US-12263464-B2 Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) 2025-04-01 US claimed
US-20240199653-A1 METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-06-20 US claimed
WO-2024123903-A1 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS GE INFRASTRUCTURE TECHNOLOGY LLC (US) 2024-06-13 WO claimed
WO-2024039914-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP GENERAL ELECTRIC TECHNOLOGY GMBH (CH) 2024-02-22 WO claimed
EP-3801880-A1 METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFS), COVALENT ORGANIC FRAMEWORKS (COFS) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFS), AND APPLICATIONS THEREOF Desiccant Rotors International Private Ltd. (IN) 2021-04-14 EP claimed
US-20210016245-A1 METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFs), COVALENT ORGANIC FRAMEWORKS (COFs) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFs), AND APPLICATIONS THEREOF DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) 2021-01-21 US claimed
US-20200291045-A1 CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2020-09-17 US claimed
EP-2739169-B1 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS MASSACHUSETTS INST TECHNOLOGY (US) 2019-06-12 EP claimed
CN-107549871-A It is a kind of to eliminate composition of harmful substance and application thereof in cigarette or air 重庆市江北区健希环保新材料科技有限公司 2018-01-09 CN claimed
CN-107185313-A Material and device for eliminating air pollutants in motor vehicle interior 昆山瑞程新美新材料有限公司 2017-09-22 CN claimed
US-8968711-B2 Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process L'OREAL (FR) 2015-03-03 US claimed
US-20140311507-A1 Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2014-10-23 US claimed
EP-2739169-A2 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS Massachusetts Institute Of Technology (US) 2014-06-11 EP claimed
WO-2013019865-A2 POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-02-07 WO claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042084-A1 SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP SRMS, TYRO3, SELE ALDH1A1 3451/4885MAPT 1454/4885SMN1; SMN2 1633/4885
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 ALDH1A1 1901/4885MAPT 2575/4885SMN1; SMN2 4595/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA ALDH1A1 1510/4885MAPT 3115/4885SMN1; SMN2 3730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.